Showing results (361-370 of 419) with videos related to

Sort By:
Pageof 42
Clinical Transplantation|February 29, 2000
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancerR P Gale, R E Park, R Dubois, et al.
The New England Journal of Medicine|September 10, 1981
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemiaR G Strauss, J E Connett, R P Gale, et al.
Leukemia & Lymphoma|May 26, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow autotransplants in newly diagnosed multiple myelomaR P Gale, R E Park, R W Dubois, et al.
The Annals of Thoracic Surgery|May 9, 2000
Stroke after coronary artery operation: incidence, correlates, outcome, and costJ D Puskas, A D Winston, C E Wright, et al.
British Medical Journal (Clinical Research Ed.)|February 28, 1981
Long survival in acute myelogenous leukaemia: an international collaborative studyJ A Whittaker, P Reizenstein, S T Callender, et al.
Leukemia Research|August 24, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remissionR P Gale, R E Park, R W Dubois, et al.
Bone Marrow Transplantation|November 26, 2013
Second transplants for multiple myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantationC O Freytes, D H Vesole, J LeRademacher, et al.
Leukemia Research|October 23, 1998
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remissionR P Gale, R E Park, R W Dubois, et al.
Leukemia Research|September 4, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phaseR P Gale, R E Park, R W Dubois, et al.
Blood|March 21, 1998
Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study GroupR P Gale, R Hehlmann, M J Zhang, et al.
Pageof 42